BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19490063)

  • 1. Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    Dullaart RP
    Eur J Clin Invest; 2009 Jun; 39(6):533. PubMed ID: 19490063
    [No Abstract]   [Full Text] [Related]  

  • 2. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose glucocorticoid therapy and lipid profile.
    Garcia-Gómez C
    Eur J Clin Invest; 2009 Jul; 39(7):626. PubMed ID: 19469801
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy.
    Bijlsma JW; van der Goes MC; Hoes JN; Jacobs JW; Buttgereit F; Kirwan J
    Ann N Y Acad Sci; 2010 Apr; 1193():123-6. PubMed ID: 20398017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Kirwan J; Power L
    Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of glucocorticoids in preventing joint destruction: Comment on the review by Schett et al.
    Kirwan JR; Boers Msc M
    Arthritis Rheum; 2009 Apr; 60(4):1202-3; reply 1203-4. PubMed ID: 19333941
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucocorticoid treatments and rheumatoid arthritis.
    Slot O
    J Rheumatol; 2007 Aug; 34(8):1784; author reply 1784. PubMed ID: 17902206
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
    Catrina AI; Klareskog L
    Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.
    Boers M; Nurmohamed MT; Doelman CJ; Lard LR; Verhoeven AC; Voskuyl AE; Huizinga TW; van de Stadt RJ; Dijkmans BA; van der Linden S
    Ann Rheum Dis; 2003 Sep; 62(9):842-5. PubMed ID: 12922956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in drug therapy for rheumatoid arthritis.
    Malaviya AN; Kaushik P
    J Assoc Physicians India; 1999 Sep; 47(9):912-7. PubMed ID: 10778664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheumatoid arthritis--diagnosis and therapy].
    Kneitz C; Tony HP
    MMW Fortschr Med; 2001 Oct; 143(41):I-VIII; quiz IX-X. PubMed ID: 11721668
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of glucocorticoids on inflammation and arthritis.
    Morand EF
    Curr Opin Rheumatol; 2007 May; 19(3):302-7. PubMed ID: 17414960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of predicting treatment response in patients with rheumatoid arthritis.
    Smolen JS; Aletaha D
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):62-3. PubMed ID: 16932630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?].
    Blanco-Morales EA; Bravo-Ferrer Acosta JM; Rubio Romero E; Gil González E; Gantes Pedraza MÁ
    Reumatol Clin; 2011; 7(6):407-11. PubMed ID: 22078702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis drug update.
    Johns Hopkins Med Lett Health After 50; 2008 May; 20(3):4-5, 7. PubMed ID: 18652033
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
    [No Abstract]   [Full Text] [Related]  

  • 18. What is meant by active disease in the NICE recommendation on use of combination therapy in early RA?
    Ezard C; Kumari R; Willott R; Butt S; Gadsby K; Deighton C
    Rheumatology (Oxford); 2012 May; 51(5):947-8. PubMed ID: 22298791
    [No Abstract]   [Full Text] [Related]  

  • 19. Corticosteroids in the management of early and established rheumatoid disease.
    Morrison E; Capell HA
    Rheumatology (Oxford); 2006 Sep; 45(9):1058-61. PubMed ID: 16880186
    [No Abstract]   [Full Text] [Related]  

  • 20. Appropriate and inappropriate use of oral glucocorticoid therapy in rheumatoid arthritis.
    Maillefert JF
    Joint Bone Spine; 2006 May; 73(3):234-5. PubMed ID: 16563844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.